Quantum BioPharma Ltd. (QNTM)

Every figure this model derived for QNTM, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2024-12-31
cash 1,905,357 CashAndCashEquivalents 2025-12-31
current assets 6,478,353 CurrentAssets 2025-12-31
current liabilities 6,058,294 CurrentLiabilities 2025-12-31
equity 6,924,475 EquityAttributableToOwnersOfParent 2025-12-31
interest expense 158,063 FinanceCosts 2025-12-31
ocf -8,237,012 CashFlowsFromUsedInOperatingActivities 2025-12-31
sbc 2,945,502 ExpenseFromSharebasedPaymentTransactionsWithEmployees 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up QNTM on one particular measure came for.

RatioValue
current ratio1.07
current ratio reported1.07
dilution pct86.43
interest cover-96.81
roic-191.29

What to be careful about

What this model itself distrusts about QNTM's figures. Written by the derivation as it ran, not added afterwards.